C07K 14/545
Il-1
C07K14/545 (Il-1) appears on 342 US grants and 356 published applications in this corpus.
Search patents in C07K- Granted patents
- 342
- Published applications
- 356
- Assignees
- 210
- Inventors
- 665
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 3 | 0 |
| 1991 | 10 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 9 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 11 | 0 |
| 1998 | 14 | 0 |
| 1999 | 16 | 0 |
| 2000 | 8 | 0 |
| 2001 | 17 | 1 |
| 2002 | 17 | 16 |
| 2003 | 13 | 24 |
| 2004 | 5 | 22 |
| 2005 | 5 | 15 |
| 2006 | 8 | 6 |
| 2007 | 19 | 9 |
| 2008 | 4 | 12 |
| 2009 | 8 | 12 |
| 2010 | 6 | 13 |
| 2011 | 8 | 10 |
| 2012 | 7 | 12 |
| 2013 | 8 | 12 |
| 2014 | 12 | 22 |
| 2015 | 7 | 11 |
| 2016 | 14 | 10 |
| 2017 | 5 | 8 |
| 2018 | 6 | 13 |
| 2019 | 15 | 17 |
| 2020 | 7 | 17 |
| 2021 | 13 | 12 |
| 2022 | 6 | 17 |
| 2023 | 7 | 20 |
| 2024 | 13 | 23 |
| 2025 | 4 | 16 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same25 Aug 2026US 12,714,755 B2Pacira Therapeutics, Inc.
- Anti-IL-1β antibody therapy in arrhythmogenic cardiomyopathy (ACM)18 Aug 2026US 12,708,665 B2Beth Israel Deaconess Medical Center, Inc.
- Methods for expansion of tumor infiltrating lymphocytes and use thereof26 May 2026US 12,637,511 B2Board of Regents, The University of Texas System
- Bicyclic peptide ligands specific for CD13719 May 2026US 12,630,588 B2BicycleTx Limited
- TGF-β polypeptides20 Jan 2026US 12,528,850 B2Cue Biopharma, Inc.
- Method for producing car-t cells23 Jul 2026US 2026/0209704 A1Takeda Pharmaceutical Company Limited
- Agents, compositions and methods for modulating immunity9 Jul 2026US 2026/0191937 A1The University of Queensland
- Fusokines involving cytokines with strongly reduced receptor binding affinities18 Jun 2026US 2026/0167687 A1Centre Hospitalier Regional Universitaire De Montpellier
- Engineered mesenchymal stem cell and use thereof14 May 2026US 2026/0130944 A1Tsinghua University
- Il-18 variant polypeptides2 Apr 2026US 2026/0092093 A1Tj Biopharma (Shanghai) Co., Ltd.
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998